Surgical Adhesion Barriers (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact)
|外科用防沾黏貼片:創傷護理市場分析·預測模式 Surgical Adhesion Barriers (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact)|
|出版日期: 2020年11月30日||內容資訊: 英文||
Surgical Adhesion Barriers (Wound Care Management) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Wound Care Management therapeutic area.
The model discusses in detail the impact of COVID-19 on Surgical Adhesion Barriers market for the year 2020 and beyond. Surgical adhesion barriers are used for the prevention of fibrous bands of scar tissue which develop after surgery and bind anatomic surfaces. These post-surgical adhesions occur in almost 95% of patients who have had multiple laparotomies.
Surgical procedures vary from cardiovascular, gastrointestinal, obstetrics, gynecological to other types of surgeries such as orthopedic and peripheral nerve operations. There are a variety of surgical adhesion barriers on the market. In order to have market appeal, the ideal adhesion barrier should have characteristics such as anti-adhesiveness, high biocompatibility, resorbable properties, adherence to traumatized surfaces, effectiveness on oozing surfaces, applicable through laparoscopes, and cost efficient.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Surgical Adhesion Barriers and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Ethicon , Sanofi Genzyme, FzioMed Inc, W. L. Gore & Associates Inc, Medtronic Plc, MAST Biosurgery, AG
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -